\
&
Contact us
\
&
Contact us
This was 3 years ago
LocationOnline
ProgrammesExperts drawn from EU Institutions, industry and academia, will discuss in 10 sessions over 5 days the latest innovations in digital infrastructures, addressing how we could expand our connectivity whilst optimising existing systems.
CONNECT University Autumn School 2022 will host an entire week on the major pillars of the digital infrastructure of the EU, exploring how this decade’s state-of-the-art solutions fit over existing ones, fostering a circular economy system while ensuring a high degree of security. Topics will include Gigabit Coverage, Microchips, Edge Computing, Data Servers, Web 3, High Performance Computing, Industrial Platforms, and 5G & Future Mobile Generations.
The speakers will discuss with the audience how these systems might evolve in the coming decade, what barriers they may face and the way digital infrastructures and technologies can interact with legacy systems in a sustainable and resource-efficient manner.
Day I, 26 September
Day II, 27 September
Day III, 28 September
Day IV, 29 September
Day V, 30 September
More information and the registration link can be found on the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
